Clinical Trials Directory

Trials / Completed

CompletedNCT01982357

Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
1 Minute – 1 Month
Healthy volunteers
Accepted

Summary

Alterations to microvascular blood flow in premature infants, are known to contribute to several major disease entities. The optically-measured tissue blood flow, to determine tissue perfusion that can be use to detect blood loss.

Detailed description

The researchers want to use optical technologies to non-invasively detect blood flow that can tell the onset of blood loss. The research can measure blood flow in stable premature infants in the Neonatal Intensive Care Unit over the duration of several weeks. The technologies are Laser Speckle Imaging and Diffuse Optical Spectroscopy. Laser Speckle Imaging non-contact imaging technology, is sensitive to blood flow in superficial tissues. Diffuse Optical Spectroscopy, a probe-based contact technology like pulse oximetry, measures hemoglobin concentrations and states deeper below the skin surface.

Conditions

Interventions

TypeNameDescription
DEVICELaser Speckle Imaging and Diffuse Optical SpectroscopyLaser Speckle Imaging and Diffuse Optical Spectroscopy

Timeline

Start date
2013-07-17
Primary completion
2015-06-30
Completion
2015-06-30
First posted
2013-11-13
Last updated
2022-11-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01982357. Inclusion in this directory is not an endorsement.